The Importance of Companion Diagnostics

Tadd Lazarus, MD, Chief Medical Officer, QIAGEN, discusses the importance of companion diagnostics.

Tadd Lazarus, MD, Chief Medical Officer, QIAGEN, discusses the importance of companion diagnostics.

Clinical Pearls I

- Diagnostics provide the foundation of care. Companion diagnostics are no exception.

- Today, about 45% of oncology drugs in the pipeline have a corresponding biomarker. Ten years ago, that number was 5-10%.

Clinical Pearls II

- Companion diagnostics allow clinicians to select the group of patients that will most likely respond to that drug.

- New drugs often have a better safety profile compared with older drugs but must be used selectively due to cost and other factors.

More on diagnostics > >